Close Menu

NEW YORK (GenomeWeb News) – Illumina today announced that Science for Life Laboratory has joined the Illumina Genome Network.

SciLifeLab, headquartered in Sweden, is the first IGN partner in Europe and the thirteenth partner in the Illumina program. It will begin a national large-scale population sequencing program aimed at identifying genetic causes of human diseases, Illumina said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.

Nov
24
Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms.